Sort
82,697 grants matching “vaccine development”
Re-engineering gp120 to include glycan-dependent epitopes
$746,619Phillip Berman · University Of California Santa Cruz · R01 · FY2015 · AI
Early HIV Effects on Gut Immunity and Inflammation for Seeding Viral Reservoirs
$746,604Satya Dandekar · University Of California At Davis · R01 · FY2019 · AI
Mimic Peptides of HIV-1 Epitopes as Vaccines
$746,470Mixture Sciences, Inc. · R44 · FY2004 · DA
Center for Humanized Mice
$746,325Larisa Y Poluektova · University Of Nebraska Medical Center · R24 · FY2016 · OD
IMPDH inhibitors for the treatment of Cryptosporidium infections
$746,322Gregory D Cuny · University Of Houston · R01 · FY2020 · AI
Synthetic Vaccine Against Human Pathogenic Bacteria
$746,291Vince Pozsgay · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Z01 · FY2008 · HD
Protein and Polysaccharide Conjugate Vaccines to enteric diseases
$746,291Shousun C Szu · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Z01 · FY2008 · HD
Determinants of retroviral replication in non-native hosts for modeling HIV infection
$746,254Amit Sharma · North Carolina State University Raleigh · R01 · FY2024 · AI
Visceral Leishmanasis in Bihar State, Indian
$746,133Shyam Sundar · Banaras Hindu University · P50 · FY2007 · AI
Development of botulinum neurotoxin immunotherapy, serotypes C, D, F, and G
$746,045James D. Marks · University Of California, San Francisco · U01 · FY2009 · AI
Adolescent Medicine Trials Unit (AMTU) Network for HIV/*
$746,016John Barringer Steever · Icahn School Of Medicine At Mount Sinai · U01 · FY2010 · HD
Improved protein-based meningococcal serogroup B vaccines
$745,990Peter T. Beernink · University Of California, San Francisco · R01 · FY2021 · AI
Genome-wide sieve analysis and immunological validation to identify targets of protective efficacy in field trials of a whole-organism malaria vaccine
$745,968Joana Carneiro Da Silva · University Of Maryland Baltimore · R01 · FY2021 · AI
Development of New Bivalent Cross-Protective Arenaviral Vaccines
$745,933Igor S. Lukashevich · University Of Louisville · R01 · FY2011 · AI
Mechanisms of environmental sensing and responses by malaria parasites
$745,853Kirk W Deitsch · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · AI
Mechanisms of environmental sensing and responses by malaria parasites
$745,853Kirk W Deitsch · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · AI
Mechanisms of environmental sensing and responses by malaria parasites
$745,853Kirk W Deitsch · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · AI
Mechanisms of environmental sensing and responses by malaria parasites
$745,853Kirk W Deitsch · Weill Medical Coll Of Cornell Univ · R01 · FY2018 · AI
Mechanisms of environmental sensing and responses by malaria parasites
$745,853Kirk W Deitsch · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · AI
Innate/ SIV DNA vaccine induced immunity in the protected macaque mucosa
$745,851Michael A Murphey-Corb · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · AI
CD4 T cell-targeted nanoparticle in vivo delivery of CRISPR/Cas9 genome editors for HIV cure
$745,808Wenhui Hu · Temple Univ Of The Commonwealth · R01 · FY2022 · AI
Pushing HIV-1 Vaccine Protection to the Mucosal Barrier
$745,752Michael A Barry · Mayo Clinic Rochester · R56 · FY2024 · AI
Novel Methods to Inform HIV/TB Clinical Trial Development
$745,684Rochelle P Walensky · Massachusetts General Hospital · R37 · FY2019 · AI
Protective versus deleterious immune responses that impact vaccine efficacy against Staphylococcus aureus bloodstream infection
$745,628M. Javad Aman · Integrated Biotherapeutics, Inc. · R01 · FY2021 · AI
Mechanisms of differential responses to whole cell and acellular pertussis vaccination
$745,616Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2020 · AI